Top Home Infusion Therapy Companies

Home Infusion Therapy Market size was valued at USD 47.51 Billion in 2024 and is poised to grow from USD 49.71 Billion in 2025 to USD 71.4 Billion by 2033, growing at a CAGR of 4.63% during the forecast period (2026–2033).

Top Players in Global Home Infusion Therapy Market 'Baxter International Inc. (USA) ', 'Fresenius Kabi AG (Germany) ', 'Teva Pharmaceutical Industries Ltd. (Israel) ', 'McKesson Corporation (USA) ', 'Option Care Health (USA) ', 'AmerisourceBergen Corporation (USA) ', 'CVS Health (USA) ', 'Walgreens Boots Alliance (USA/UK) ', 'Cardinal Health (USA) ', 'Linde plc (UK) ', 'Centene Corporation (USA) ', 'UnitedHealth Group (USA) ', 'Anthem, Inc. (USA) ', 'Humana Inc. (USA) ', 'Cigna Corporation (USA) ', 'Koninklijke Philips N.V. (Netherlands) ', 'Smiths Medical (UK) ', 'ICU Medical, Inc. (USA) ', 'Terumo Corporation (Japan) ', 'BD (USA)'

The rising prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular disorders, is a significant driver of the global home infusion therapy market size. With the increasing number of people needing chronic care and medication, home infusion therapy is one of the simplest and most effective options that reduce hospital visits and increase comfort levels of patients. 

Shift Towards Patient-Centric Care: The global home infusion therapy market trends will soon evolve to emphasize patient-centered care by increasing patient-specific treatment plans. This trend is influenced by the increasing desire for ease and comfort thus enabling patients to control chronic diseases from the home setting with minimal hospital visits and lower care costs. 

The global home infusion therapy market is largely dominated by North America due to a number of reasons such as the presence of developed healthcare systems, high technological adoption rates and an increase in the population that is elderly and suffers from chronic medical illnesses that need continuous care. New devices such as smart pumps and continuous glucose monitors that have emerged into the market are helping improve patient compliance and also assist in management of blood sugar levels. In fact, self-management and cost-effective care are on the rise leading to the need for better home infusion therapies for the patients. North America's home infusion therapy market share is fueled by the presence of key market players and continuous infusion technology advancements.